Slovakia
Tuberculosis profile
Population  2013 5.5 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.035 (0.035–0.035) 0.64 (0.64–0.65)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.58 (0.27–1) 11 (5–18)
Incidence  (includes HIV+TB) 0.42 (0.38–0.45) 7.7 (6.9–8.2)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.02 (0.01–0.03)
Case detection, all forms (%) 95 (89–110)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0 (0–2.6) 3.7 (0.09–19)
MDR-TB cases among notified pulmonary
TB cases
0 (0–7) 2 (0–11)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 182   38
Pulmonary, clinically diagnosed 103   18
Extrapulmonary 56   1
       
Total new and relapse 398    
Previously treated, excluding relapses 3    
Total cases notified 401    
Among 398 new and relapse cases:
38 (10%) cases aged under 15 years; male:female ratio: 1.7
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 174 (96%) 44 (73%) 224
Laboratory-confirmed RR-/MDR-TB cases     8
Patients started on MDR-TB treatment     7
TB/HIV 2013 Number (%)
TB patients with known HIV status 368 (92)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0  
HIV-positive TB patients on antiretroviral therapy (ART) 0  
HIV-positive people screened for TB 274  
HIV-positive people provided with IPT 0  
Treatment success rate (%)
New and relapse cases registered in 2012 88
Previously treated cases, excluding relapse, registered in 2012 100
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011 33
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions) <1
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-09-05 Data: www.who.int/tb/data